These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21736534)

  • 1. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
    Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of CYP allelic variation on antidepressant metabolism: a review.
    Black JL; O'Kane DJ; Mrazek DA
    Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):21-31. PubMed ID: 17269892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in molecular modeling of human cytochrome P450 polymorphism.
    Martiny VY; Miteva MA
    J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
    Sim SC; Ingelman-Sundberg M
    Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
    Singh MS; Francis PA; Michael M
    Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in FKBP5 affecting response to antidepressant drug treatment.
    Kirchheiner J; Lorch R; Lebedeva E; Seeringer A; Roots I; Sasse J; Brockmöller J
    Pharmacogenomics; 2008 Jul; 9(7):841-6. PubMed ID: 18597649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of rat P450 genetic polymorphism on diazepam metabolism.
    Sakai N; Ishizuka M
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1421-33. PubMed ID: 19689220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.
    Brockmöller J; Kirchheiner J; Meisel C; Roots I
    Pharmacogenomics; 2000 May; 1(2):125-51. PubMed ID: 11256586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antidepressant pharmacokinetics during pregnancy].
    Maslovskiĭ SIu
    Eksp Klin Farmakol; 2013; 76(1):14-20. PubMed ID: 23461010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].
    Jeleń A; Sałagacka A; Balcerczak E
    Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.
    Schwaiblmair M; Behr W; Foerg W; Berghaus T
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1547-60. PubMed ID: 22070131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.
    Altar CA; Hornberger J; Shewade A; Cruz V; Garrison J; Mrazek D
    Int Rev Psychiatry; 2013 Oct; 25(5):509-33. PubMed ID: 24151799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.